What is the current valuation of the Influenza Tests Devices Market?

As of 2024, the market valuation stands at 0.4387 USD Billion. Read More

What is the projected market size for the Influenza Tests Devices Market in 2035?

The market is projected to reach 0.9236 USD Billion by 2035. Read More

What is the expected CAGR for the Influenza Tests Devices Market from 2025 to 2035?

The market is expected to grow at a CAGR of 7.0% during the forecast period. Read More

Which companies are the key players in the Influenza Tests Devices Market?

Key players include Abbott, Roche, Thermo Fisher Scientific, BD, Siemens Healthineers, QuidelOrtho, Hologic, Cepheid, and BioMerieux. Read More

What was the market size for Influenza Multiplex NAATs in 2024?

In 2024, the market size for Influenza Multiplex NAATs was 0.175 USD Billion. Read More

What is the projected market size for Influenza Antigen Tests by 2035?

The market for Influenza Antigen Tests is projected to reach 0.3 USD Billion by 2035. Read More

How did the market for Influenza Lowplex NAATs perform in 2024?

The market for Influenza Lowplex NAATs was valued at 0.1137 USD Billion in 2024. Read More

What trends are influencing the growth of the Influenza Tests Devices Market?

The growth appears to be driven by advancements in testing technology and increasing demand for rapid diagnostic solutions. Read More

How does the performance of the Influenza Tests Devices Market compare across its segments?

The Influenza Multiplex NAATs segment shows the highest growth potential, followed by Influenza Antigen Tests and Influenza Lowplex NAATs. Read More

Influenza Tests Devices Market

Q: What are the main segments within the Influenza Tests Devices Market?

The main segments include Influenza Multiplex NAATs, Influenza Antigen Tests, and Influenza Lowplex Nucleic Acid Amplification Tests (NAATs). Read More

ID: MRFR/HC/14563-HCR

128 Pages

Vikita Thakur

Last Updated: May 15, 2026

Influenza Tests Devices Market Research Report Information By Tests (Influenza Multiplex NAATs, Influenza Antigen Tests, and Influenza Lowplex Nucleic Acid Amplification Tests (NAATs)), And By Region (North America, Europe, Asia-Pacific, And Rest of The World) –Market Forecast Till 2035

Influenza Tests Devices Market Infographic

Summary Table of Contents Segmentation Methodology Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Tests (USD Billion)
  1. 4.1.1 Influenza Multiplex NAATs
  2. 4.1.2 Influenza Antigen Tests
  3. 4.1.3 Influenza Lowplex Nucleic Acid Amplification Tests (NAATs)
2. 4.2 Healthcare, BY Region (USD Billion)
  1. 4.2.1 North America
    1. 4.2.1.1 US
    2. 4.2.1.2 Canada
  2. 4.2.2 Europe
    1. 4.2.2.1 Germany
    2. 4.2.2.2 UK
    3. 4.2.2.3 France
    4. 4.2.2.4 Russia
    5. 4.2.2.5 Italy
    6. 4.2.2.6 Spain
    7. 4.2.2.7 Rest of Europe
  3. 4.2.3 APAC
    1. 4.2.3.1 China
    2. 4.2.3.2 India
    3. 4.2.3.3 Japan
    4. 4.2.3.4 South Korea
    5. 4.2.3.5 Malaysia
    6. 4.2.3.6 Thailand
    7. 4.2.3.7 Indonesia
    8. 4.2.3.8 Rest of APAC
  4. 4.2.4 South America
    1. 4.2.4.1 Brazil
    2. 4.2.4.2 Mexico
    3. 4.2.4.3 Argentina
    4. 4.2.4.4 Rest of South America
  5. 4.2.5 MEA
    1. 4.2.5.1 GCC Countries
    2. 4.2.5.2 South Africa
    3. 4.2.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Abbott (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Roche (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Thermo Fisher Scientific (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 BD (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Siemens Healthineers (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 QuidelOrtho (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Hologic (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Cepheid (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 BioMerieux (FR)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY TESTS
4. 6.4 CANADA MARKET ANALYSIS BY TESTS
5. 6.5 EUROPE MARKET ANALYSIS
6. 6.6 GERMANY MARKET ANALYSIS BY TESTS
7. 6.7 UK MARKET ANALYSIS BY TESTS
8. 6.8 FRANCE MARKET ANALYSIS BY TESTS
9. 6.9 RUSSIA MARKET ANALYSIS BY TESTS
10. 6.10 ITALY MARKET ANALYSIS BY TESTS
11. 6.11 SPAIN MARKET ANALYSIS BY TESTS
12. 6.12 REST OF EUROPE MARKET ANALYSIS BY TESTS
13. 6.13 APAC MARKET ANALYSIS
14. 6.14 CHINA MARKET ANALYSIS BY TESTS
15. 6.15 INDIA MARKET ANALYSIS BY TESTS
16. 6.16 JAPAN MARKET ANALYSIS BY TESTS
17. 6.17 SOUTH KOREA MARKET ANALYSIS BY TESTS
18. 6.18 MALAYSIA MARKET ANALYSIS BY TESTS
19. 6.19 THAILAND MARKET ANALYSIS BY TESTS
20. 6.20 INDONESIA MARKET ANALYSIS BY TESTS
21. 6.21 REST OF APAC MARKET ANALYSIS BY TESTS
22. 6.22 SOUTH AMERICA MARKET ANALYSIS
23. 6.23 BRAZIL MARKET ANALYSIS BY TESTS
24. 6.24 MEXICO MARKET ANALYSIS BY TESTS
25. 6.25 ARGENTINA MARKET ANALYSIS BY TESTS
26. 6.26 REST OF SOUTH AMERICA MARKET ANALYSIS BY TESTS
27. 6.27 MEA MARKET ANALYSIS
28. 6.28 GCC COUNTRIES MARKET ANALYSIS BY TESTS
29. 6.29 SOUTH AFRICA MARKET ANALYSIS BY TESTS
30. 6.30 REST OF MEA MARKET ANALYSIS BY TESTS
31. 6.31 KEY BUYING CRITERIA OF HEALTHCARE
32. 6.32 RESEARCH PROCESS OF MRFR
33. 6.33 DRO ANALYSIS OF HEALTHCARE
34. 6.34 DRIVERS IMPACT ANALYSIS: HEALTHCARE
35. 6.35 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
36. 6.36 SUPPLY / VALUE CHAIN: HEALTHCARE
37. 6.37 HEALTHCARE, BY TESTS, 2024 (% SHARE)
38. 6.38 HEALTHCARE, BY TESTS, 2024 TO 2035 (USD Billion)
39. 6.39 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TESTS, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY TESTS, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY TESTS, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY TESTS, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY TESTS, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY TESTS, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY TESTS, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY TESTS, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY TESTS, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY TESTS, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY TESTS, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY TESTS, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY TESTS, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY TESTS, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY TESTS, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY TESTS, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY TESTS, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY TESTS, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY TESTS, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY TESTS, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY TESTS, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY TESTS, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY TESTS, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY TESTS, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY TESTS, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY TESTS, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY TESTS, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY TESTS, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY TESTS, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Tests (USD Billion, 2025-2035)

Influenza Multiplex NAATs
Influenza Antigen Tests
Influenza Lowplex Nucleic Acid Amplification Tests (NAATs)

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓